Chair Warmer
Membership Revoked
J&J recalls more Tylenol, over-the-counter drugs
By Ransdell Pierson – Thu Jul 8, 6:12 pm ET
NEW YORK (Reuters) – Johnson & Johnson recalled more Tylenol and other over-the-counter drugs on Thursday after they were linked to a musty or moldy odor, expanding a recall the company started in January.
J&J's McNeil Consumer Healthcare unit said the latest recall involved 21 lots of medications, including Tylenol for children and adults, several forms of Benadryl allergy tablets and Motrin painkiller. But it did not say how many pieces were in each lot or give a total number of items involved. J&J spokeswoman Bonnie Jacobs said, "We do not have that information."
The lots were sold in the United States, Fiji, Guatemala, the Dominican Republic, Puerto Rico, Trinidad and Tobago and Jamaica, J&J said.
Thursday's recall, like one three weeks ago, was related to J&J's January 15 recall of 53 million bottles of widely used products, which were also linked to odors.
On June 15, J&J recalled four lots of Benadryl and one lot of Extra Strength Tylenol gels.
Consumer complaints of odors traced to a chemical called TBA present in wooden pallets used to ship and store the medications led to the January recall.
"These lots are being added to the list of recalled products as a precautionary measure after a continuing internal review determined that some packaging materials used in the lots had been shipped and stored on the same type of wooden pallet that was tied to the presence of TBA in earlier recalled lots," J&J said in a press statement.
People who bought products included in the recall should stop taking them and contact the company about a refund or replacement, J&J said.
"This recall does raise questions surrounding why there wasn't a more exhaustive recall initially and whether there is an adequate system in place that can readily identify every product that has been affected," said Kurt Bardella, spokesman for Rep. Darrell Issa (R-CA), ranking member of the House Committee on Oversight and Government Reform.
Excluding actions following up on the January 15 recall, McNeil has issued four product recalls in the past year due to quality control problems at its plants, sparking a congressional investigation and scrutiny from the U.S. Food and Drug Administration.
FDA spokeswoman Elaine Gansz Bobo said the FDA would post information on Thursday's recall on its website.
One of McNeil's three main factories, located in Ft. Washington, Pennsylvania, has been closed while the company addresses problems cited by the FDA.
J&J shares closed up 77 cents, or 1.3 percent, at $61.38 on the New York Stock Exchange, in line with the Dow Jones industrial average.
(Reporting by Ransdell Pierson; Additional reporting by Bill Berkrot in New York and Susan Heavey in Washington; Editing by Toni Reinhold)
http://news.yahoo.com/s/nm/20100708/ts_nm/us_johnsonandjohnson_recall
By Ransdell Pierson – Thu Jul 8, 6:12 pm ET
NEW YORK (Reuters) – Johnson & Johnson recalled more Tylenol and other over-the-counter drugs on Thursday after they were linked to a musty or moldy odor, expanding a recall the company started in January.
J&J's McNeil Consumer Healthcare unit said the latest recall involved 21 lots of medications, including Tylenol for children and adults, several forms of Benadryl allergy tablets and Motrin painkiller. But it did not say how many pieces were in each lot or give a total number of items involved. J&J spokeswoman Bonnie Jacobs said, "We do not have that information."
The lots were sold in the United States, Fiji, Guatemala, the Dominican Republic, Puerto Rico, Trinidad and Tobago and Jamaica, J&J said.
Thursday's recall, like one three weeks ago, was related to J&J's January 15 recall of 53 million bottles of widely used products, which were also linked to odors.
On June 15, J&J recalled four lots of Benadryl and one lot of Extra Strength Tylenol gels.
Consumer complaints of odors traced to a chemical called TBA present in wooden pallets used to ship and store the medications led to the January recall.
"These lots are being added to the list of recalled products as a precautionary measure after a continuing internal review determined that some packaging materials used in the lots had been shipped and stored on the same type of wooden pallet that was tied to the presence of TBA in earlier recalled lots," J&J said in a press statement.
People who bought products included in the recall should stop taking them and contact the company about a refund or replacement, J&J said.
"This recall does raise questions surrounding why there wasn't a more exhaustive recall initially and whether there is an adequate system in place that can readily identify every product that has been affected," said Kurt Bardella, spokesman for Rep. Darrell Issa (R-CA), ranking member of the House Committee on Oversight and Government Reform.
Excluding actions following up on the January 15 recall, McNeil has issued four product recalls in the past year due to quality control problems at its plants, sparking a congressional investigation and scrutiny from the U.S. Food and Drug Administration.
FDA spokeswoman Elaine Gansz Bobo said the FDA would post information on Thursday's recall on its website.
One of McNeil's three main factories, located in Ft. Washington, Pennsylvania, has been closed while the company addresses problems cited by the FDA.
J&J shares closed up 77 cents, or 1.3 percent, at $61.38 on the New York Stock Exchange, in line with the Dow Jones industrial average.
(Reporting by Ransdell Pierson; Additional reporting by Bill Berkrot in New York and Susan Heavey in Washington; Editing by Toni Reinhold)
http://news.yahoo.com/s/nm/20100708/ts_nm/us_johnsonandjohnson_recall
